EGFR and non-small cell lung carcinoma: Importantly, this method using an EGFR-TKI-based chemical probe provides fully quantitative measurements of EGFR expression and functional activity, showing fairly good sensitivity and specificity for predicting EGFR-TKI sensitivity in EGFR-mutant NSCLC.